• Hyalolex for Alzheimer’s and other cannabis-based drugs for pain, epilepsy, and more are raising the market valuation growth potential for IGC
• Phytocannabinoids target protein receptors in the brain, peripheral nervous system and other parts of the body, including the lungs, liver, and other organs
• Cannabidiol makes up as much as 40 percent of cannabis-plant extract and has more potential medical uses than THC

Cannabinoid receptors have been known in the medical community since 1988. India Globalization Capital, Inc. (NYSE MKT: IGC) is the first company to develop revolutionary cannabis-based pharmaceuticals targeting Alzheimer’s. Based on this alone, the company’s market valuation growth potential is high, given the possibilities now recognized for these compounds. IGC has a deep pipeline of products, including recently announced therapies such as IGC-501, for arthritic and neuropathic pain; IGC-502 for canine seizures; and IGC-504 for cachexia, a syndrome often associated with debilitating diseases such as multiple sclerosis, Parkinson’s and cancer.

The potential for growth is strong, as cannabis companies such as Anavex Life Sciences Corp. (NASDAQ: AVXL), AC Immune Ltd. (NASDAQ: ACIU) and others have seen market valuations in the hundreds of millions of dollars and even higher.

While there is no cure for Alzhimer’s, therapies, such as the one IGC is pursuing for Alzheimer’s, hold promise in addressing the disease. Phytocannabinoid treatments are also effective because of the protein receptors in the brain and other tissues of the body. There are several different types; one includes the G protein-coupled receptor family, activated by endocannabinoids the body synthesizes when under stress. These receptors play a role in pain modulation, appetite, mood, and even memory.

There are also CB1 receptors, which are thought to be expressed at the synapses in the brain. They have also been found in the peripheral nerves and in muscle, liver, and lung tissue, as well as in fat. Aside from being associated with pain regulation, these cannabinoid receptors have effects on emotion, sensory perception, memory, cognition, and movement. Some autonomous functions are affected as well. Found in the immune system, CB2 receptors have anti-inflammatory properties and other functions, being based in T cells and B cells. They have also been found in macrophages and hematopoietic cells.

Evidence suggests there are more types of cannabinoid receptors. The known types are activated naturally by endocannabinoids but can also be stimulated by compounds found in cannabis plants and by synthetic cannabinoids, which helped researchers identify the receptors in the first place.

Until recently, it was tetrahydrocannabinol that had the attention of mainstream media, known for its psychotropic effects. However, cannabidiol (CBD), which constitutes up to 40 percent of plant extracts, seems to have more medical applications. It’s widely believed to have anti-psychotic, anti-depressive, anxiety-reducing, and anti-convulsive effects. Therefore, CBD has the potential to be useful to the 50 million people around the world with refractory, or drug resistant, epilepsy; the 1.3 million individuals in the United States affected by cachexia every year; the 5.3 million people in the country with Alzheimer’s disease; and the millions who suffer from chronic pain.

For more information, visit the company’s website at www.IGCInc.us

The world’s most popular form of cryptocurrency – bitcoin – has an enigmatic beginning. Its mysterious founder, Satoshi Nakamoto, bears a fictitious name that has kept the curious guessing as to his/her (or their) identity since bitcoin was created in 2009. In the 2016 movie, “Banking on Bitcoin,” no less than four men are identified as the mystic namesake. Three deny the nomenclature, although the last man, Australian computer scientist Craig Steven Wright, claims to be the elusive founder of bitcoin (http://dtn.fm/Jn6ZB).

Nakamoto’s idea – to develop a digital encrypted currency that can be exchanged for any other traditional currency used throughout the world – has both fascinated and confused the public. Virtual money inherently means there’s no physical currency to have and to hold. That idea made a lot of people nervous and many others interested in it.

After all, if you could purchase your favorite brew, spend a night in America’s iconic Sin City (Las Vegas, of course), or hop on a plane simply by paying with digital currency backed up by no one, would you do it? You can do all these things and more (including ordering a $35,000 Tesla 3) with bitcoin (http://dtn.fm/5nlR3).

Bitcoin’s ballistic rise to prominence in the financial world and virtual pocketbooks of average folks deserves some explanation. This monetary revolution found its niche following the September 2008 financial crisis, when the stock market dived, plunging investors into losses that some are still in the process of recovering from today.

Bitcoin is defined by bitcoin.org as “an innovative payment network and a new kind of money.” It is a peer-to-peer payment network with no middleman. Users send and receive bitcoin within the network of those honoring the system.

The unique thing about bitcoin is that it is transparent. Your personal data can’t be shared, just your transactions and the amounts spent. Everything is tracked and followed on a blockchain, and that’s what instills trust and security among those using bitcoin. To enable this process, bitcoin uses software that anonymously logs and validates the activities of bitcoin users around the globe (http://dtn.fm/UE4kz).

There’s no physical money, but there are a finite number of bitcoin that can be created – 21 million, to be exact. A digital wallet holds your bitcoin, and there are usually few or no associated fees. While you are free to spend your bitcoin as you see fit, refunds are not possible, and, if you lose your digital wallet, well, let’s just say you are going to have a very bad, no-good day. James Howell can attest to that. He lost 7,500 bitcoin worth £4 million by throwing his hard drive away (http://dtn.fm/FB4Hg).

Once bitcoin took off as a legitimate digital currency, its rise in value jumped. From the first exchange of a single bitcoin in 2009 to its current value of over $4,000 today, the cryptocurrency continues to rise. For context, on May 22, 2010, two pizzas were purchased with 10,000 bitcoin worth about $25. In December 2013, those same bitcoin were worth about $7 million, and, by May 2017, the value had jumped to $20 million, making that first bitcoin purchase likely the most expensive lunch in history (http://dtn.fm/tEaR7).

In 2013, Overstock.com became the first major U.S. retailer to accept the digital currency. “We think there’s going to be a market in Bitcoin and we want to get in front of it,” Overstock’s CEO at the time, Patrick Byrne, said in an interview with bitcoin blog newsBTC. “It will put [Overstock] at a competitive edge if, and only if, the general population starts thinking and using bitcoin,” he said (http://dtn.fm/mw6Dh). “We’re willing to take the first step and see.”

Other popular online companies like Newegg, Microsoft and Expedia are also accepting bitcoin. In fact, the number of merchants accepting bitcoin has grown to over 82,000, and there are more than 1,350 bitcoin ATMs worldwide in 55 countries. However, there are still some countries where buying or using bitcoin is either illegal or banned; among them are Vietnam, Iceland, Bolivia, Ecuador, Kyrgyzstan and Bangladesh (http://dtn.fm/5uDNS).

This article wouldn’t be complete without asking, “What’s some of the weirdest things you can buy with Bitcoin?” Among the real-life purchases possible with the cybercurrency are a $1,795 motorized unicycle, two adult Canadian woolly mammoth tusks for $175,000 and a $29 bright yellow, cozy handmade bitcoin plush pillow. Who knows… 10 years from now that pillow could be a highly valued collector’s item (http://dtn.fm/4oKZE).

• Nasdaq Hearings Panel grants decision on listing based on shareholder equity and minimum bid issues, conditional on NETE providing evidence of compliance by October 20, 2017
• NETE says impact of its cost cutting program should be realized by the third quarter of 2017
• Zack’s Research Report projects that NETE will generate sales of $74.6 million by FY2018

Net Element, Inc.’s (NASDAQ: NETE) common stock will continue to be traded on the Nasdaq Capital Market after the company met with the exchange’s Nasdaq Hearings Panel. The panel’s decision to grant the company’s request is conditional on NETE providing evidence of compliance with Nasdaq’s regulations by October 20, 2017, as noted by the company in a news release (http://dtn.fm/AN4sa).

NETE is a cloud-based financial company that accepts electronic payments in an omni-channel environment. The payments are processed at point-of-sale and on mobile devices. The firm also offers management tools for clients. A Zack’s Research report projected that NETE would generate $74.6 million in sales by 2018 (http://dtn.fm/6HWor).

NETE received an initial letter from Nasdaq explaining that, because the company was no longer in compliance with its regulations concerning shareholders’ equity and minimum bid price, its stock would be delisted. In a meeting afterward, NETE presented its plan for Nasdaq regulation compliance on both issues.

“We are working diligently to comply with Nasdaq’s listing requirements while improving shareholder value,” Oleg Firer, chief executive officer of NETE, stated in a news release. However, the company said there can be no assurance it will cure its stockholders’ equity or bid price deficiencies.

Nasdaq requires $2.5 million in shareholder equity. The exchange cited NETE’s shareholder equity of only $1,975,435 for the quarter ended June 30. The exchange also has a regulation requiring a $1 minimum bid.

In a July 2017 letter to shareholders, NETE said its institution of a cost cutting program should be realized by the third quarter of 2017.

For more information, visit the company’s website at www.NetElement.com

• Founded in 1999 to offer financial information to Chinese-speaking investors
• Identifies and executes opportunistic strategies in colossal markets
• Positioning to lead in Chinese CBD and cryptocurrency markets

There’s a lot to like about a company that can swiftly identify opportunity and execute on its strategy. ChineseInvestors.com, Inc. (OTCQB: CIIX) is one company that doesn’t waste time. The company was founded in 1999 to offer real-time market commentary, analysis and educational services to Chinese-speaking investors via its dynamic financial website, www.Chinesefn.com. Success followed, and CIIX steadily increased subscribers to currently exceed one hundred thousand. Armed with insights garnered from years of market analysis, CIIX has consistently looked for growth opportunities for expansion.

In 2016, the company recognized the unprecedented growth opportunity in the legal cannabis industry, where the market is projected to continue to grow at a 27 percent CAGR through 2021 (http://dtn.fm/ACwm4). Once the target market was identified, ChineseInvestors.com started laying the groundwork to capitalize on the growing demand for cannabidiol-based (CBD) nutrition and health products, with a natural focus on Chinese-speaking markets. By the end of 2016, the company had begun implementing its plans for a new website and mobile application in order to facilitate online distribution of CBD oils for the booming global medical marijuana industry. While marijuana use in China is illegal, cannabis-based oils, including hemp-based CBDs, are legal, thus opening a potential market of nearly two billion people for CIIX.

Since launch, the company has continued to identify new markets and expansion targets. Recognizing the enormous untapped market for cannabis-based skin care products, CIIX quickly developed and filed with the China Food and Drug Administration to launch a new skin care line over the next couple months. This quick action will put CIIX first to market with immense upside potential.

Now, the company has latched on to another rapid market mover in cryptocurrencies. The underlying blockchain technology of bitcoin and other cryptocurrencies has the potential to transform transactional business by transferring value anywhere around the world without the need of traditional intermediaries such as clearing firms or banks. The ability to transfer value solely through software could become a transformational breakthrough. It’s no coincidence that the Chinese are dominant players in bitcoin mining and volume.

Just two weeks ago, CIIX announced the launch of a cryptocurrency education and trading subscription service (http://dtn.fm/Fi5eJ). The company also announced plans to launch the first Chinese daily video news broadcast from the NYSE covering cryptocurrency and blockchain technology (http://dtn.fm/y2Kp2).

CIIX continues to identify market openings with colossal upside opportunity, but, even more importantly, CIIX moves rapidly to capitalize on these opportunities.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

• Company is carving out a niche in a burgeoning market
• Canada’s oil extraction market projected to reach $1.5 billion by 2020
• Impending blanket legalization has poised Canada’s marijuana market for explosive growth

The legal marijuana industry is growing by leaps and bounds in North America—particularly in Canada, where medical cannabis has been nationally legal since 2001 and where Canada’s government has now introduced sweeping legislation aimed at making recreational marijuana use legal by July 2018. Canada-based Algae Dynamics Corp. (OTCQB: ADYNF) is among the cannabis stocks preparing to cash in on the influx of business that is sure to follow such an event.

Algae Dynamics is focused on cannabis oil extraction and medicine delivery systems, endeavoring to offer medical cannabis users a means of enjoying the benefits of medical marijuana without smoking. The company is preparing to exploit a niche market with its development of unique health products and pharmaceuticals utilizing hemp, cannabis and algae oils.

If recreational cannabis is successfully legalized on a national scale, Canada’s market for oil extraction is projected to grow to C$1.5 billion by 2020. In Colorado, 45 percent of cannabis consumers who use dried marijuana have said they would eventually switch over to marijuana extracts and oil, and a similar conversion rate is anticipated for Canada’s market. In view of this, Algae Dynamics is extremely well-positioned for success.

Algae Dynamics has engaged two premier universities to perform research into the various uses of cannabis and hemp oil extracts. In combination with other compounds, cannabis and hemp oil extracts could prove effective in the treatment of colorectal, pancreatic, breast and prostate cancers, as well as in the development of novel pharmacotherapies to treat various mental health conditions.

Algae Dynamics is poised for great success in Canada’s favorable cannabis environment. The legal status of medical marijuana has already positioned the company for profitability, and the impending legalization of recreational marijuana is likely to take Algae Dynamics even further.

For more information, visit the company’s website at www.AlgaeDynamics.com

Let us hear your thoughts: Algae Dynamics Corp. Message Board

• SeeThruEquity initiates coverage of PotNetwork Holding, Inc., sees CAGR in hemp-derived CBD market of 53% through 2020
• Diamond CBD sales achieved at BIG Industry Trade Show, Market Week Event and CHAMPS
• SeeThruEquity estimates company will do $8.3 million in revenue in FY2017, a 712% year-over-year jump

PotNetwork Holding, Inc.’s (OTC: POTN) subsidiary, Diamond CBD Sales, achieved greater than $200,000 in sales at the Big Industry Trade Show in New York on August 10-11 (http://dtn.fm/c4AOh). The show is a leading business-to-business trade show for the vape and smoke industry. In total, at three convention and trade shows within the past month, the subsidiary rang up more than $820,000 in revenues, per updates from PotNetwork Holding.

PotNetwork Holding holds First Capital Venture Corp., which owns Diamond CBD, Inc., a major player in the cannabidiol (CBD) industry marketing brands nationally, in all 50 states, as well as internationally, including CBD Gummies, Chill Gummies, CBD Liquid Gold, Blue CBD and many others.

SeeThruEquity has initiated coverage of PotNetwork Holding, setting a target price of $0.25 per share (http://dtn.fm/YX4tU). The report sees the company as a high-risk, high-reward stock in the growing legal cannabis and hemp industry. The target price assumes the market will expand and the company will be successful in its aggressive marketing campaigns. It sees the hemp-derived CBD market as growing at a compound annual growth rate (CAGR) of 53% through 2020.

In addition to the $200,000 at the BIG Industry Trade Show, Diamond CBD also generated sales of more than $320,000 at the Market Week Event, held in Las Vegas. Late in July, the firm also recorded revenues of some $300,000 at the CHAMPS trade show in Las Vegas, PotNetwork Holding said.

Exhibitors at the BIG Industry Trade Show include manufacturers, distributors, store owners and wholesalers in the counter-culture vape and smoke industry. Diamond CBD’s team includes pioneers of the hemp industry, as well as scientists, chemists, and other experts.

For more information, visit the company’s website at www.PotNetworkHolding.com

Let us hear your thoughts: PotNetwork Holding, Inc. Message Board

• Environmentally-controlled growing chambers generate consistent, superior quality
• Proprietary technologies eliminate risk, ensuring patients enjoy peace of mind
• Publicly-traded ABcann entered funding deal for $15 million at $2.25 per share

The Canadian government’s recent announcement that Broken Coast Cannabis Ltd. is recalling several products sold last year after two banned pesticides were found in random samples illustrates the importance of ABcann Global Corp.’s (TSX.V: ABCN) (OTCQB: ABCCF) controlled, pesticide-free approach to growing medical marijuana (http://dtn.fm/8ZOgn).

Several other cannabis-growing Canadian companies also reaped the attention of authorities following mandatory testing. Hydropothecary and Peace Naturals both had products recalled earlier this year following detection of banned pesticides in some products, while Supreme Pharmaceuticals Inc. is still awaiting its license from Health Canada to grow and sell medical cannabis (http://dtn.fm/CS5es).

In contrast, ABcann’s flagship production facility in Napanee, Ontario, continues to meet demand, even as its expansion plans move forward with an expedited construction timeline announced last month (http://dtn.fm/d1JLJ).

“ABcann has moved methodically through each stage of our growth since first obtaining our license in 2014,” founder and director Ken Clement said in an update published on the company’s website. “Providing a high quality, standardized pesticide-free product to our patients remains our number one priority as we initiate our largest expansion plans to date.”

ABcann has approximately $43 million in cash and 100 percent ownership of a 65-acre parcel located not far from its current facility. Phase 1 of the expansion project includes building a 100,000 square foot facility with an annual production capacity of about 1,000 kilograms of cannabis (http://dtn.fm/7cDSD).

A recent $15 million investment in the company by Cannabis Wheaton, part of a $30 million commitment, underscores the company’s belief in ABcann’s tremendous potential for growth (http://dtn.fm/q3PCC).

ABcann’s commitment to growing and providing standardized quality products for the medical marijuana community is a critical component of its future growth plans. The company’s mission, says Clement, is “to deliver consistent, standardized medical cannabis that the public and patients can consistently rely on.”

For more information, visit the company’s website at www.ABcann.ca

Let us hear your thoughts: ABcann Global Corp. Message Board

• 2017 second quarter net revenues up 18 percent to $16.1 million
• PayOnline, a flexible e-commerce payment solutions platform, launches in U.S.
• Net Element is strategically poised for growth in the U.S. and emerging countries

Mobile-based purchasing by the world’s consumers is booming thanks to smartphones and other portable devices. Net Element (NASDAQ: NETE) is tapping into that expanding e-commerce world with its focus on small- to medium-sized businesses in the United States and select emerging markets.

Florida-based Net Element is a global financial technology company delivering a wide range of value-added solutions that support electronic payments in an omni-channel environment that spans point-of-sale, e-commerce, and mobile devices.

Its PayOnline subsidiary, launched July 2017 in the United States, supports more than 100 payment methods in as many currencies, in addition to credit card acceptance, and it is certified with most payment processors in the United States and globally.

PayOnline’s Instant Payment Module utilizes chat-bots with four popular instant messaging apps to help retailers interact with consumers, which Net Element believes represents a global opportunity for the company.

This major consumer habit of buying online, fueled by millennials, bodes well for Net Element and its long-term growth opportunities as e-commerce markets expand.

An online retail forecast from Forrester, cited by Digital Commerce 360, predicts that U.S. shoppers will splurge on nearly $460 billion in online sales in 2017, proving the global marketplace is ripe for Net Element’s ideas (http://dtn.fm/w4DoU).

“We are pleased with our continued growth. Our results are a reflection of our ability to deliver growth,” Oleg Firer, CEO of Net Element, said prior to the company’s August 15 conference call to discuss second quarter 2017 financial results and business highlights. “We are excited about our strategic initiatives for the remainder of the year as we continue to streamline international operations and reduce operating expenses while managing the strong U.S. growth and expansion.”

For more information, visit the company’s website at www.NetElement.com

• Training programs already offered in 22 states
• Upending traditional approach to delivering education and training
• Employing VR technology to cut costs and improve accessibility

Taking Francis Bacon’s aphorism ‘if the mountain will not go to Mohammed, then Mohammed must go to the mountain’ to heart, ProBility Media Corp. (OTCQB: PBYA) plans to deliver its extensive suite of technical training programs nationwide through virtual reality and a host of other cutting edge technologies. At present, the company offers programs in 22 states, so it is already halfway to realizing its ambitious goal. Partnering with developers of three-dimensional (3D) technology, ProBility will create virtual reality and interactive media content designed specifically for education and training purposes. The innovative edtech company wants nothing less than to create the first full service training and career advancement brand for technical vocations and trades.

Recent innovations in information technology have expanded the bounds of countless industries, and the field of education is no different. Historically, delivering educational services meant the construction of costly infrastructure such as schools, colleges, and laboratories, as well as funding emoluments for teachers and instructors. In addition, this model placed the provision of services in one fixed location. Like a mountain, a college or training facility cannot move, which means that not only Mohammed but students must oftentimes travel for long distances, perhaps relocate, if they wish to attend a particular school.

This traditional approach affects the market for education from both the demand and the supply ends. Supply quantity is curtailed, since building schools and community colleges is expensive. Likewise, demand quantity is dampened because of high tuition costs and the inevitable barriers to availability and accessibility, both adverse outcomes resulting because schools can’t go to students. That’s why ProBility’s approach, which takes schooling to students, is such a big deal, killing, as it does, two birds with one stone. With ProBility’s eLearning VR educational programs, a student can sit in the comfort of his or her home and enjoy all the benefits of a classroom or lab environment.

The potential for a nationwide expansion of ProBility’s eLearning programs is promising. The market for employer-based formal training is estimated at around $177 billion annually. Most of that (52%) is in service industries, with manufacturing accounting for 14%; transportation and utilities another 11%; finance, insurance and real estate 9%; and retail 9%. Construction and mining together account for 4% of total spending on employer-based formal training.

A recent New York Times piece (http://dtn.fm/d4G3b) detailed how West Virginia ‘is now leading the way in turning vocational education from a Plan B for underachieving students into what policy makers hope will be a fuel source for the state’s economic revival. Simulated workplaces, overseen by teachers newly trained in important state industries like health, coal and even fracking, are now operating in schools across the state. Students punch a time clock, are assigned professional roles like foreman or safety supervisor, and are even offered several vacation days of their choice in addition to regular school breaks.’

VR technology is currently employed to deliver ProBility’s crane training programs. ProBility has collaborated with GlobalSim, a VR Crane industry leader, to offer a cutting-edge VR simulation platform that combines a comprehensive training program with superb realism, all at an affordable price. The GlobalSim VR simulator comes equipped with a headset that offers an unlimited field-of-view in a mixed reality setting, allowing for a completely immersive experience. Just as with traditional simulator systems, the GlobalSim VR platform uses real equipment controls, joysticks and buttons, so operators can become familiar with the actual equipment they will use in the workplace.

As part of its strategy to offer training programs in crane operation, ProBility also signed an exclusive publishing and distribution deal with All Purpose Crane Training (AP), which provides nationwide crane-rigging training and certification that meets OSHA-ANSI requirements. OSHA is the Occupational Safety and Health Administration; ANSI is the American National Standards Institute.

The courses, customized to meet the specific needs of customers, can be taken either at the customer’s site or at AP’s training centers around the country. They include aerial lift operator training, forklift operator certification, crane rigging instructor courses, mobile crane operator certification, crane operator training, overhead crane training, and rigging and signal-person qualification training.

For more information, visit the company’s website at www.ProbilityMedia.com

Let us hear your thoughts: ProBility Media Corp. Message Board

• Alzheimer’s is America’s most expensive disease, with a new diagnosis every 66 seconds
• IGC’s unique use of marijuana extracts in combination therapy for potential Alzheimer’s breakthrough shows promise
• Low market cap could make IGC a big winner for early investors

Alzheimer’s disease is one of the greatest medical, ethical, and financial challenges facing society today. Currently, more than 5.3 million Americans and their families have to deal with Alzheimer’s disease, and projections suggest that number will nearly triple to 14 million Americans by 2050. Globally, the figures are even more staggering, with about 47 million people worldwide currently diagnosed and projections at 132 million in less than three decades. Right now, someone in America develops Alzheimer’s every 66 seconds, and soon, this deadly diagnosis is expected to occur every 33 seconds.

Alzheimer’s is already the country’s most expensive disease. In 2016 U.S. costs totaled $236 billion and global costs exceeded $600 billion. These figures will skyrocket unless scientists develop new approaches to prevent or cure this insidious disease. Given the magnitude of the problem, pharmaceutical companies are scrambling to find ways to mitigate the disease’s devastation.

With so much on the line, it’s no wonder that Wall Street has already started to place bets on who might be a winner in this race. In this vein, Goldman Sachs recently highlighted Biogen (NASDAQ: BIIB) and its lead pipeline Alzheimer’s drug as one of the first to possibly prevent or slow the progression of the disease (http://dtn.fm/QoqT5). Goldman pegged potential drug sales at over $12 billion and targeted the $60 billion market cap stock at a 17 percent premium, if successful. However, everyone knows there are no guaranteed winners in this race. A broad spectrum of options must be considered if investors want to participate in the enormous upside potential of an effective Alzheimer’s treatment.

One compelling candidate with a promising patent pending Alzheimer’s treatment protocol and ridiculously low market valuation is India Globalization Capital (NYSE MKT: IGC). IGC is a pioneer in the development of new classes of phytocannabinoid pharmaceuticals with broad therapeutic applications for both humans and animals. IGC’s pipeline of patented and patent pending therapeutics include treatments for pain, post-traumatic stress disorder, cachexia, neurologic disorders, Parkinson’s, and, now, Alzheimer’s disease.

IGC recently acquired the exclusive rights to its novel THC-based treatment for Alzheimer’s disease from the University of South Florida (http://www.igcinc.us/alzheimers-disease/). The patent identifies discovery of a new pathway in which low doses of THC bind to amyloid beta plaques and prevent those plaques from aggregating on neurons, which is exactly what occurs in Alzheimer’s disease and causes cognitive decline.

IGC plans to enter clinical trials this year on its potential cannabis-based blockbuster treatment for Alzheimer’s, as well as on the company’s primary pipeline of other major therapeutics that address large market maladies. Any one of these trials could provide breakthrough treatments for previously untreatable disease. With a market capitalization currently around $10 million, IGC is one very interesting bet investors may want to place in this race for an effective Alzheimer’s treatment. Any positive results from the clinical trials could easily catapult valuation and make IGC a big winner for early investors.

For more information, please visit www.IGCInc.us